Success Story: Advancing Neurocognitive and Mental Health Outcomes for Childhood Cancer Survivors: NIW Approval Secured for a Psycho-Oncology Researcher from Italy

Client’s Testimonial:

 

“I am very thankful to Chen Immigration for the hard work they put into my NIW petition to secure a smooth approval without any RFE. The team is very detail-oriented and knowledgeable, and was always available to answer any question in a timely manner. I highly recommend their service!”

 


 

On September 30th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Clinical Research Scientist I in the field of Psycho-Oncology (Approval Notice).

 


 

General Field: Psycho-Oncology

 

Position at the Time of Case Filing: Clinical Research Scientist I

 

Country of Origin: Italy

 

State of Residence at the Time of Filing: Tennessee

 

Approval Notice Date: September 30th, 2026

 

Processing Time: 4 months, 26 days (Premium Processing Upgrade Requested)

 


 

Case Summary:

 

We are pleased to share the NIW approval of a psycho-oncology researcher whose work focuses on improving long-term outcomes for childhood cancer survivors. The client’s proposed endeavor combines survey data, psychological assessments, neuroimaging, clinical evaluations, and epidemiological methods to identify modifiable risk factors associated with psychiatric and neurocognitive impairments and to develop interventions that can improve survivors’ long-term health and quality of life. At the time of filing, the client was employed as a Clinical Research Scientist I at a U.S. research institution, where she continued research involving neurocognitive impairment, survivorship outcomes, and intervention development.

 

Research with National Importance

 

The client’s research addresses the lasting psychological, cognitive, and functional challenges experienced by childhood cancer survivors. By identifying modifiable risk factors and evaluating evidence-based interventions, her work can support earlier identification of survivors at risk for long-term impairment and improve strategies to support mental health, cognitive functioning, independence, and survivorship care. The petition further connected her endeavor to U.S. priorities involving childhood cancer survivorship, public health, healthcare efficiency, and health innovation.

 

Academic Contributions and Recognition

 

At the time of filing, the client had documented her research in 9 peer-reviewed journal articles, including 8 first-authored publications, and 18 abstracts, including 10 first-authored abstracts. Her published work had received 440 citations. She had also completed at least 23 peer reviews for scholarly journals, demonstrating recognition of her expertise in psycho-oncology, neurocognitive science, developmental neuropsychology, and mental health research.

 

The petition further demonstrated the client’s significance through the citation impact and independent use of her research. Three of her papers ranked among the top 1%, two among the top 10%, and another among the top 20% most-cited articles in Psychiatry/Psychology for their respective years of publication. Independent researchers had also relied on her findings in studies involving neurocognitive outcomes, psychological health, social functioning, and long-term survivorship, providing additional evidence of the influence of her work.

 

NIW Approval and Outlook

 

The I-140 NIW petition was filed on May 4th, 2026, later upgraded to Premium Processing, and approved on September 30th, 2026. The approval recognized the national importance of the client’s work in identifying modifiable factors that affect the mental health, cognitive functioning, and long-term quality of life of childhood cancer survivors.

 

This outcome supports the client’s continued efforts to advance evidence-based survivorship research and develop interventions that promote greater independence and healthier long-term outcomes for childhood cancer survivors. We congratulate her on this approval and wish her continued success in her research.